Skip to content

Author

Sarah Khan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Metronomic capecitabine in metastatic triple negative breast cancer.

Objective: To evaluate the efficacy and safety of metronomic capecitabine in patients with metastatic TNBC (mTNBC), with progression free survival (PFS) as primary end point and toxicity profile as secondary endpoint. Study Design: Retrospective study. Setting: Department of Radiotherapy, Quaid e Azam Medical College,...

A. Luqman, Sarah Khan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.